Conn. Agencies Regs. § 20-631-3

Current through December 4, 2024

Section 20-631-3 - Content of patient protocol

A written protocol for a specific patient established pursuant to a collaborative drug therapy management agreement shall include, but need not be limited to, the following:

(1) The specific drug or drugs to be managed by the pharmacist;

(2) The terms and conditions under which drug therapy may be implemented, modified or discontinued;

(3) The conditions and events that the pharmacist is required to report to the physician;

(4) The laboratory tests that may be ordered by the pharmacist; and

(5) The drugs that may be administered by the pharmacist.

Conn. Agencies Regs. § 20-631-3

Effective January 2, 2013